1. Home
  2. FNWB vs PYPD Comparison

FNWB vs PYPD Comparison

Compare FNWB & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$10.05

Market Cap

86.7M

Sector

Finance

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.90

Market Cap

85.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
PYPD
Founded
1923
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.7M
85.1M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
FNWB
PYPD
Price
$10.05
$4.90
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$13.50
$12.25
AVG Volume (30 Days)
25.4K
116.2K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
0.70%
N/A
EPS Growth
36.00
N/A
EPS
N/A
N/A
Revenue
$176,000.00
N/A
Revenue This Year
$19.24
N/A
Revenue Next Year
$8.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.05
$2.79
52 Week High
$10.98
$5.20

Technical Indicators

Market Signals
Indicator
FNWB
PYPD
Relative Strength Index (RSI) 59.24 59.43
Support Level $9.18 $4.15
Resistance Level $10.34 $5.05
Average True Range (ATR) 0.29 0.27
MACD 0.04 0.02
Stochastic Oscillator 82.57 70.59

Price Performance

Historical Comparison
FNWB
PYPD

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It offers various products and services, such as commercial business loans, multi-family real estate loans, auto and consumer loans, transaction accounts, savings and money market accounts, online banking services, etc., focused on the lending, deposit, and money movement needs of individuals, businesses and nonprofit organizations. The Group's operations are mainly focused on serving various communities in Washington State, U.S. Substantially all of its income is derived from a diverse base of commercial, mortgage, and consumer lending activities and investments.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: